In case you battle with darkish spots, hyperpigmentation or uneven pores and skin tone, there’s a very good likelihood La Roche-Posay’s Mela B3 line is already in your skin-care radar. Now, the model is increasing the gathering, and the one-and-only Keke Palmer is again to assist inform the story.
La Roche-Posay has renewed its partnership with the actress, singer, entrepreneur and podcast host, persevering with a collaboration that first launched in 2024 and shortly resonated with shoppers on the lookout for efficient, inclusive options for discoloration. Palmer will stay the face of Mela B3 by academic campaigns, digital content material and community-driven initiatives centered on pores and skin confidence and science-backed skincare.
“Working with La Roche-Posay has been awesome,” Palmer says. “I get to have fun and lean into the humor of the fact that they are so scientific.”
The marketing campaign kicks off this month throughout La Roche-Posay’s social channels, alongside an unique cowl with PAPER Journal that celebrates Palmer’s continued partnership with the model.
The components is powered by a dual-action mixture of one-percent Melasyl and Proxylane. Melasyl is L’Oréal’s multi-patented pigment-correcting ingredient and the powerhouse behind the Mela B3 assortment, which the model says is clinically confirmed to visibly cut back a broad vary of discoloration, from post-acne marks to cussed darkish spots, throughout all pores and skin tones.
The science is compelling, however so is what’s driving it. When Mela B3 launched in 2024, La Roche-Posay surveyed 23,000 individuals and located that just about half of respondents coping with pigmentary issues—circumstances like melasma, photo voltaic lentigo and post-inflammatory hyperpigmentation—reported a reasonable to extraordinarily important impression on their high quality of life. The ripple results had been putting: 22 % reported feeling considered as soiled, 23 % felt handled in a different way throughout administrative procedures and 21 % stated that they had skilled discrimination at work.
These numbers underscore why Palmer’s involvement appears like greater than a celeb partnership. All through 2026, she’ll proceed displaying up in dermatologist conversations, social-first content material and marketing campaign rollouts as La Roche-Posay continues working to make hyperpigmentation care extra seen, inclusive and accessible.
The Mela B3 Double Dose Discoloration Therapy is on the market now at LaRoche-Posay.us.
La Roche-Posay
Mela B3 Double Dose with Melasyl
BUY NOW – $55
